Galustian C - Search Results

1

The anti-cancer agents lenalidomide and pomalidomide inhibit the proliferation and function of T regulatory cells.

Galustian C, Meyer B, Labarthe MC, Dredge K, Klaschka D, Henry J, Todryk S, Chen R, Muller G, Stirling D, Schafer P, Bartlett JB, Dalgleish AG. Galustian C, et al. Cancer Immunol Immunother. 2009 Jul;58(7):1033-45. doi: 10.1007/s00262-008-0620-4. Epub 2008 Nov 14. Cancer Immunol Immunother. 2009. PMID: 19009291 Free PMC article.

2

Thalidomide-derived immunomodulatory drugs as therapeutic agents.

Galustian C, Labarthe MC, Bartlett JB, Dalgleish AG. Galustian C, et al. Expert Opin Biol Ther. 2004 Dec;4(12):1963-70. doi: 10.1517/14712598.4.12.1963. Expert Opin Biol Ther. 2004. PMID: 15571458 Review.

3

Impact of surgery on immunologic function: comparison between minimally invasive techniques and conventional laparotomy for surgical resection of colorectal tumors.

Evans C, Galustian C, Kumar D, Hagger R, Melville DM, Bodman-Smith M, Jourdan I, Gudgeon AM, Dalgleish AG. Evans C, et al. Among authors: galustian c. Am J Surg. 2009 Feb;197(2):238-45. doi: 10.1016/j.amjsurg.2008.01.021. Epub 2008 Jul 17. Am J Surg. 2009. PMID: 18639228

4

Lenalidomide: a novel anticancer drug with multiple modalities.

Galustian C, Dalgleish A. Galustian C, et al. Expert Opin Pharmacother. 2009 Jan;10(1):125-33. doi: 10.1517/14656560802627903. Expert Opin Pharmacother. 2009. PMID: 19236186 Review.

5

The effect of colorectal cancer upon host peripheral immune cell function.

Evans CF, Galustian C, Bodman-Smith M, Dalgleish AG, Kumar D. Evans CF, et al. Among authors: galustian c. Colorectal Dis. 2010 Jun;12(6):561-9. doi: 10.1111/j.1463-1318.2009.01819.x. Epub 2009 Feb 24. Colorectal Dis. 2010. PMID: 19250260

6

T-regulatory cell modulation: the future of cancer immunotherapy?

Nizar S, Copier J, Meyer B, Bodman-Smith M, Galustian C, Kumar D, Dalgleish A. Nizar S, et al. Among authors: galustian c. Br J Cancer. 2009 Jun 2;100(11):1697-703. doi: 10.1038/sj.bjc.6605040. Epub 2009 Apr 21. Br J Cancer. 2009. PMID: 19384299 Free PMC article. Review.

7

Recent advances and developments in treatment strategies against pancreatic cancer.

Fryer RA, Galustian C, Dalgleish AG. Fryer RA, et al. Among authors: galustian c. Curr Clin Pharmacol. 2009 May;4(2):102-12. doi: 10.2174/157488409788185007. Curr Clin Pharmacol. 2009. PMID: 19442075 Review.

8

A microarray study of altered gene expression in colorectal cancer cells after treatment with immunomodulatory drugs: differences in action in vivo and in vitro.

Liu WM, Laux H, Henry JY, Bolton TB, Dalgleish AG, Galustian C. Liu WM, et al. Among authors: galustian c. Mol Biol Rep. 2010 Apr;37(4):1801-14. doi: 10.1007/s11033-009-9614-3. Epub 2009 Jul 14. Mol Biol Rep. 2010. PMID: 19597962

9

Inhibition of metastatic potential in colorectal carcinoma in vivo and in vitro using immunomodulatory drugs (IMiDs).

Liu WM, Henry JY, Meyer B, Bartlett JB, Dalgleish AG, Galustian C. Liu WM, et al. Among authors: galustian c. Br J Cancer. 2009 Sep 1;101(5):803-12. doi: 10.1038/sj.bjc.6605206. Epub 2009 Jul 28. Br J Cancer. 2009. PMID: 19638977 Free PMC article.

10

T regulatory cells, the evolution of targeted immunotherapy.

Nizar S, Meyer B, Galustian C, Kumar D, Dalgleish A. Nizar S, et al. Among authors: galustian c. Biochim Biophys Acta. 2010 Aug;1806(1):7-17. doi: 10.1016/j.bbcan.2010.02.001. Epub 2010 Feb 23. Biochim Biophys Acta. 2010. PMID: 20188145 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

49 results

Search Page